Gary Lee
Chief Tech/Sci/R&D Officer en LYELL IMMUNOPHARMA, INC. .
Fortuna: 28 321 $ al 31/03/2024
Perfil
Gary Lee is currently the Chief Scientific Officer at Lyell Immunopharma, Inc. He was previously the Vice President-Cell Therapy at Sangamo Therapeutics, Inc. from 2005 to 2018 and the Chief Scientific Officer at Senti Sub I, Inc. from 2018 to 2022.
He received his undergraduate degree from the California Institute of Technology and his doctorate from the University of California, Berkeley.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
LYELL IMMUNOPHARMA, INC.
0.00% | 09/02/2024 | 12 700 ( 0.00% ) | 28 321 $ | 31/03/2024 |
Cargos activos de Gary Lee
| Empresas | Cargo | Inicio |
|---|---|---|
| LYELL IMMUNOPHARMA, INC. | Chief Tech/Sci/R&D Officer | 31/01/2022 |
Antiguos cargos conocidos de Gary Lee.
| Empresas | Cargo | Fin |
|---|---|---|
Senti Sub I, Inc.
 Senti Sub I, Inc. BiotechnologyHealth Technology Senti Biosciences, Inc. develops novel therapeutics. It specializes in thetic biology, gene therapy and cell therapy. The company was founded by Timothy K. Lu, Wilson Wong, James J. Collins and Philip Lee in 2016 and is headquartered in South San Francisco, CA. | Chief Tech/Sci/R&D Officer | 01/01/2022 |
| SANGAMO THERAPEUTICS, INC. | Corporate Officer/Principal | 01/10/2018 |
Formación de Gary Lee.
| California Institute of Technology | Undergraduate Degree |
| University of California, Berkeley | Doctorate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| SANGAMO THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Senti Sub I, Inc.
Senti Sub I, Inc. BiotechnologyHealth Technology Senti Biosciences, Inc. develops novel therapeutics. It specializes in thetic biology, gene therapy and cell therapy. The company was founded by Timothy K. Lu, Wilson Wong, James J. Collins and Philip Lee in 2016 and is headquartered in South San Francisco, CA. | Health Technology |
| Lyell Immunopharma, Inc. |
- Bolsa de valores
- Insiders
- Gary Lee
